These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34033981)

  • 1. Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome.
    Kaakati R; Khokhar D; Akin C
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3198-3199. PubMed ID: 34033981
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms.
    Giannetti MP; Weller E; Alvarez-Twose I; Torrado I; Bonadonna P; Zanotti R; Dwyer DF; Foer D; Akin C; Hartmann K; Rama TA; Sperr WR; Valent P; Teodosio C; Orfao A; Castells M
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2083-2086. PubMed ID: 33631409
    [No Abstract]   [Full Text] [Related]  

  • 3. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama T; Álvarez-Twose I
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).
    Bonadonna P; Brockow K; Niedoszytko M; Elberink HO; Akin C; Nedoszytko B; Butterfield JH; Alvarez-Twose I; Sotlar K; Schwaab J; Jawhar M; Castells M; Sperr WR; Hermine O; Gotlib J; Zanotti R; Reiter A; Broesby-Olsen S; Bindslev-Jensen C; Schwartz LB; Horny HP; Radia D; Triggiani M; Sabato V; Carter MC; Siebenhaar F; Orfao A; Grattan C; Metcalfe DD; Arock M; Gulen T; Hartmann K; Valent P
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2139-2144. PubMed ID: 33831618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
    Rama TA; Moreira A; Castells M
    J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 infection and vaccination in 92 pediatric patients with cutaneous mastocytosis: A retrospective, cross-sectional study.
    López Sanz P; Guerrero Ramírez C; Manso Córdoba S; Alfaro Martínez ME; Bascuñana Mendoza A; Gómez Sánchez ME; Martínez Martínez ML; Azaña Defez JM
    Pediatr Dermatol; 2024; 41(3):458-460. PubMed ID: 38305078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of COVID-19 vaccination in patients with clonal mast cell disorders.
    Ruano-Zaragoza M; Carpio-Escalona LV; Diaz-Beya M; Piris-Villaespesa M; Castaño-Diez S; Muñoz-Cano R; González-de-Olano D
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1374-1376.e3. PubMed ID: 35121156
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders.
    Giannetti MP; Olivieri F; Godwin G; Weller E; Nicoloro-SantaBarbara J; Bonadonna P; Zanotti R; Zanoni G; Hartmann K; Castells M
    Allergy; 2023 Jan; 78(1):301-304. PubMed ID: 35962620
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis.
    Tuncay G; Bostan OC; Damadoglu E; Karakaya G; Kalyoncu AF
    Ann Allergy Asthma Immunol; 2022 Jun; 128(6):733-734. PubMed ID: 35257871
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.
    Rosman Y; Lavi N; Meir-Shafrir K; Lachover-Roth I; Cohen-Engler A; Mekori YA; Confino-Cohen R
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3487-3489. PubMed ID: 34224924
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies.
    Payandeh Z; Mohammadkhani N; Nabi Afjadi M; Khalili S; Rajabibazl M; Houjaghani Z; Dadkhah M
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):899-910. PubMed ID: 33307883
    [No Abstract]   [Full Text] [Related]  

  • 12. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
    Salzman MB; Huang CW; O'Brien CM; Castillo RD
    Emerg Infect Dis; 2021 Jul; 27(7):1944-1948. PubMed ID: 34034858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccination complicated by small fiber neuropathy, mast cell activation syndrome, and pericarditis.
    Hertz D; Scorza FA; Fiorini AC; Finsterer J
    Clinics (Sao Paulo); 2023; 78():100304. PubMed ID: 37956597
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report.
    Criscuolo M; Salmanton-García J; Fracchiolla N; Dragonetti G; Khanna N; Weinbergerová B; Schönlein M; Machado M; Labrador J; Kolditz M; Itri F; Gomes Da Silva M; Bonuomo V; Sciumè M; Nunes Rodrigues R; Gräfe S; Marchesi F; Cornely OA; Pagano L
    J Investig Allergol Clin Immunol; 2023 Jun; 33(3):225-227. PubMed ID: 35894666
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccination in Pregnancy: The Benefits Outweigh the Risks.
    Chavan M; Qureshi H; Karnati S; Kollikonda S
    J Obstet Gynaecol Can; 2021 Jul; 43(7):814-816. PubMed ID: 34253304
    [No Abstract]   [Full Text] [Related]  

  • 17. Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report.
    Paul G; Chad R
    BMC Pediatr; 2021 Mar; 21(1):138. PubMed ID: 33752624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.
    Mueller T
    Clin Chim Acta; 2021 Jul; 518():9-16. PubMed ID: 33741357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
    Mayo S; Monfort S
    J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
    [No Abstract]   [Full Text] [Related]  

  • 20. [Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].
    Dabanch J; Bastías M; Endeiza ML; Díaz E; Inostroza J; Cerda J; Santillana S; Rodríguez J; González C; Rodríguez M; Pizarro A
    Rev Chilena Infectol; 2021 Apr; 38(2):185-188. PubMed ID: 34184708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.